Fortress Biotech, Inc. (FBIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-91,192
-60,637
-86,575
-64,703
-46,526
Depreciation & amortisation
8,442
8,075
9,353
6,791
5,325
Stock-based compensation
24,518
17,029
22,987
19,486
13,451
Change in working capital
14,489
-12,519
-715
36,373
-4,781
Accounts receivable
3,080
12,551
-5,380
768
-10,438
Inventory
2,425
3,953
1,744
-8,458
-547
Accounts payable
13,690
-24,382
8,349
43,307
11,101
Other working capital
-176,424
-136,323
-182,456
-132,886
-90,846
Other non-cash items
6,631
8,733
3,477
24,435
10,488
Net cash provided by operating activities
-170,253
-128,225
-179,401
-116,540
-83,682
Cash flows from investing activities
Investments in property, plant and equipment
-6,171
-8,098
-3,055
-16,346
-7,164
Acquisitions, net
0
0
-20,000
0
0
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
-
0
Other investing activities
-5
-5
-
-
-
Net cash used for investing activities
30,816
-2,103
-22,928
40,514
-7,164
Cash flows from financing activities
Debt repayment
-17,450
-81,323
-2,864
-16,638
-89,671
Common stock issued
72,816
80,376
40,258
155,255
170,603
Common stock repurchased
-400
-400
-1,196
0
-70
Dividends paid
-8,782
-8,768
-8,780
-8,780
-6,752
Other financing activities
-5,260
-1,089
-7,124
-5,401
-9,377
Net cash used provided by (used for) financing activities
95,642
32,739
75,319
148,994
172,410
Net change in cash
-43,795
-97,589
-127,010
72,968
81,564
Cash at beginning of period
254,366
180,954
307,964
234,996
153,432
Cash at end of period
210,571
83,365
180,954
307,964
234,996
Free cash flow
Operating cash flow
-170,253
-128,225
-179,401
-116,540
-83,682
Capital expenditure
-6,171
-8,098
-3,055
-16,346
-7,164
Free cash flow
-176,424
-136,323
-182,456
-132,886
-90,846
© 2024 Yahoo. All rights reserved.